Agilon Health, Inc. (NYSE:AGL) Given Consensus Recommendation of “Hold” by Brokerages

Posted by George Bondi on Jul 28th, 2026

Agilon Health, Inc. (NYSE:AGL – Get Free Report) has received an average recommendation of “Hold” from the fourteen ratings firms that are covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $66.50.

A number of equities analysts have issued reports on the company. Barclays upgraded Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 price target for the company in a research note on Tuesday, May 26th. TD Cowen reaffirmed a “hold” rating and set a $55.00 target price (up from $17.00) on shares of Agilon Health in a research report on Monday, May 11th. Jefferies Financial Group raised Agilon Health from a “hold” rating to a “buy” rating and increased their price target for the company from $27.50 to $48.00 in a research report on Thursday, May 7th. Benchmark restated a “buy” rating and set a $95.00 price objective (up from $13.00) on shares of Agilon Health in a research note on Thursday, May 21st. Finally, Wall Street Zen raised shares of Agilon Health from a “sell” rating to a “hold” rating in a report on Saturday, May 9th.

Read Our Latest Report on AGL

Agilon Health Stock Down 0.3%

Agilon Health stock opened at $97.69 on Thursday. Agilon Health has a 1-year low of $7.48 and a 1-year high of $133.04. The firm has a market capitalization of $1.63 billion, a price-to-earnings ratio of -4.53 and a beta of 2.98. The firm’s fifty day moving average price is $105.19 and its two-hundred day moving average price is $51.67. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08.

Agilon Health (NYSE:AGL – Get Free Report) last posted its earnings results on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, topping the consensus estimate of $1.04 by $0.76. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. The company had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.38 billion. On average, equities research analysts predict that Agilon Health will post -3.5 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

A number of institutional investors have recently added to or reduced their stakes in the company. AQR Capital Management LLC lifted its position in shares of Agilon Health by 243.3% during the 1st quarter. AQR Capital Management LLC now owns 501,440 shares of the company’s stock worth $2,171,000 after buying an additional 355,365 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Agilon Health by 3.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock valued at $927,000 after acquiring an additional 7,209 shares during the last quarter. Dynamic Technology Lab Private Ltd lifted its holdings in Agilon Health by 28.4% during the first quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock worth $204,000 after acquiring an additional 10,424 shares during the period. Goldman Sachs Group Inc. boosted its position in Agilon Health by 6.6% in the first quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company’s stock worth $21,911,000 after purchasing an additional 311,158 shares during the last quarter. Finally, Creative Planning grew its stake in Agilon Health by 17.6% in the 2nd quarter. Creative Planning now owns 170,969 shares of the company’s stock valued at $393,000 after purchasing an additional 25,548 shares during the period.

Agilon Health Company Profile

(Get Free Report)

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.